1AD1 Stock Overview
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
AddLife AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr8.52 |
| 52 Week High | kr12.21 |
| 52 Week Low | kr4.59 |
| Beta | 1.22 |
| 1 Month Change | -8.29% |
| 3 Month Change | -12.31% |
| 1 Year Change | -22.02% |
| 3 Year Change | -60.80% |
| 5 Year Change | n/a |
| Change since IPO | 34.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1AD1 | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | 4.5% | -0.7% | -1.0% |
| 1Y | -22.0% | -14.6% | 2.0% |
Return vs Industry: 1AD1 underperformed the German Life Sciences industry which returned -14.6% over the past year.
Return vs Market: 1AD1 underperformed the German Market which returned 2% over the past year.
Price Volatility
| 1AD1 volatility | |
|---|---|
| 1AD1 Average Weekly Movement | 6.0% |
| Life Sciences Industry Average Movement | 6.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1AD1 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1AD1's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1906 | 2,289 | Fredrik Dalborg | www.add.life |
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments.
AddLife AB (publ) Fundamentals Summary
| 1AD1 fundamental statistics | |
|---|---|
| Market cap | €1.07b |
| Earnings (TTM) | €6.70m |
| Revenue (TTM) | €841.51m |
159.4x
P/E Ratio1.3x
P/S RatioIs 1AD1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1AD1 income statement (TTM) | |
|---|---|
| Revenue | kr9.80b |
| Cost of Revenue | kr6.16b |
| Gross Profit | kr3.64b |
| Other Expenses | kr3.56b |
| Earnings | kr78.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 15, 2024
| Earnings per share (EPS) | 0.64 |
| Gross Margin | 37.17% |
| Net Profit Margin | 0.80% |
| Debt/Equity Ratio | 95.9% |
How did 1AD1 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield78%
Payout RatioDoes 1AD1 pay a reliable dividends?
See 1AD1 dividend history and benchmarks| AddLife dividend dates | |
|---|---|
| Ex Dividend Date | May 10 2024 |
| Dividend Pay Date | May 16 2024 |
| Days until Ex dividend | 4 days |
| Days until Dividend pay date | 10 days |
Does 1AD1 pay a reliable dividends?
See 1AD1 dividend history and benchmarks